Verition Fund Management LLC boosted its position in Agilent Technologies Inc (NYSE:A) by 37.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 23,661 shares of the medical research company’s stock after purchasing an additional 6,488 shares during the period. Verition Fund Management LLC’s holdings in Agilent Technologies were worth $1,585,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its stake in shares of Agilent Technologies by 1.6% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 48,835 shares of the medical research company’s stock worth $3,385,000 after buying an additional 771 shares during the period. Signature Estate & Investment Advisors LLC raised its stake in Agilent Technologies by 7.3% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 11,406 shares of the medical research company’s stock valued at $764,000 after purchasing an additional 773 shares during the period. Nordea Investment Management AB raised its stake in Agilent Technologies by 4.9% during the 3rd quarter. Nordea Investment Management AB now owns 16,484 shares of the medical research company’s stock valued at $1,058,000 after purchasing an additional 774 shares during the period. Penserra Capital Management LLC raised its stake in Agilent Technologies by 18.6% during the 4th quarter. Penserra Capital Management LLC now owns 5,320 shares of the medical research company’s stock valued at $356,000 after purchasing an additional 836 shares during the period. Finally, Weatherly Asset Management L. P. raised its stake in Agilent Technologies by 18.3% during the 4th quarter. Weatherly Asset Management L. P. now owns 5,668 shares of the medical research company’s stock valued at $380,000 after purchasing an additional 876 shares during the period.
In related news, VP Rodney Gonsalves sold 6,825 shares of the business’s stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $71.23, for a total transaction of $486,144.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Patrick Kaltenbach sold 6,875 shares of the business’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $71.38, for a total value of $490,737.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 116,670 shares of company stock valued at $8,317,523.
Several analysts recently issued reports on the company. Robert W. Baird reissued a “buy” rating and set a $76.00 target price on shares of Agilent Technologies in a research note on Thursday, January 18th. JPMorgan Chase & Co. lifted their target price on Agilent Technologies from $75.00 to $80.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $80.00 target price on the stock in a research note on Tuesday. Barclays lifted their target price on Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a research note on Tuesday, November 21st. Finally, Deutsche Bank set a $75.00 target price on Agilent Technologies and gave the company a “buy” rating in a research note on Tuesday, November 21st. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $71.27.
Agilent Technologies Inc (A) opened at $70.18 on Friday. The company has a market capitalization of $22,564.39, a P/E ratio of 118.95, a PEG ratio of 2.34 and a beta of 1.30. The company has a quick ratio of 2.78, a current ratio of 3.23 and a debt-to-equity ratio of 0.40. Agilent Technologies Inc has a 1-year low of $52.26 and a 1-year high of $75.00.
Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 14th. The medical research company reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.08. The firm had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.16 billion. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. During the same quarter in the previous year, the business earned $0.53 EPS. research analysts forecast that Agilent Technologies Inc will post 2.68 earnings per share for the current year.
WARNING: “Verition Fund Management LLC Increases Holdings in Agilent Technologies Inc (A)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/03/16/verition-fund-management-llc-increases-holdings-in-agilent-technologies-inc-a.html.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.